These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25631648)

  • 1. Editorial: Treatment for NASH - helping the liver or helping the heart?
    Armstrong MJ; Newsome PN
    Aliment Pharmacol Ther; 2015 Mar; 41(5):487. PubMed ID: 25631648
    [No Abstract]   [Full Text] [Related]  

  • 2. Nutrition and metabolism: non-alcoholic fatty liver disease - pathogenesis, cardiovascular risk and therapy.
    Watts GF; Gan SK
    Curr Opin Lipidol; 2008 Feb; 19(1):92-4. PubMed ID: 18196992
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments on: predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients.
    Kabir A
    Acta Med Iran; 2015; 53(2):143. PubMed ID: 25725187
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
    Rafiq N; Younossi ZM
    Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease in HIV infection.
    Sánchez-Torres RJ; García-Palmieri MR
    P R Health Sci J; 2006 Sep; 25(3):249-54. PubMed ID: 17203795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of non-alcoholic fatty liver disease on cardiovascular disease].
    Ampuero J; Romero-Gómez M
    Gastroenterol Hepatol; 2012 Oct; 35(8):585-93. PubMed ID: 22541252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.
    Vanwagner LB; Bhave M; Te HS; Feinglass J; Alvarez L; Rinella ME
    Hepatology; 2012 Nov; 56(5):1741-50. PubMed ID: 22611040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter?
    Domanski JP; Park SJ; Harrison SA
    J Clin Gastroenterol; 2012; 46(5):427-30. PubMed ID: 22469639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.
    Musso G; Gambino R; Cassader M; Pagano G
    Ann Med; 2011 Dec; 43(8):617-49. PubMed ID: 21039302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients.
    Ghamar-Chehreh ME; Khedmat H; Amini M; Taheri S
    Acta Med Iran; 2013 May; 51(5):307-13. PubMed ID: 23737314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.
    Rahimi RS; Landaverde C
    Nutr Clin Pract; 2013 Feb; 28(1):40-51. PubMed ID: 23286927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity in childhood].
    Shcherbakova MIu; Poriagina GI; Kovaleva EA
    Eksp Klin Gastroenterol; 2010; (7):74-83. PubMed ID: 21033087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver disease in obese children--relation to other metabolic risk factors.
    Volovelsky O; Weiss R
    Int J Pediatr Obes; 2011 Sep; 6 Suppl 1():59-64. PubMed ID: 21905818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus statement on the management of dyslipidaemias in adults.
    ; ; ; Béliard S; Bonnet F; Bouhanick B; Bruckert E; Cariou B; Charrière S; Durlach V; Moulin P; Valéro R; Vergès B
    Diabetes Metab; 2016 Dec; 42(6):398-408. PubMed ID: 27659248
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma.
    Hessheimer AJ; Forner A; Varela M; Bruix J
    Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1239-44. PubMed ID: 20505515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Risk and Cardiac Rehabilitation 2015: A Selection of Topical Issues.
    Castro Conde A; Marzal Martín D; Dalmau González-Gallarza R; Arrarte Esteban V; Morillas Bueno M; García-Moll Marimón X; Berenguel Senén A; Murga N; Abeytua M
    Rev Esp Cardiol (Engl Ed); 2016 Mar; 69(3):294-9. PubMed ID: 26794287
    [No Abstract]   [Full Text] [Related]  

  • 17. News from the literature: focus on joint ESC/EAS dyslipidemia guidelines.
    Stock J
    Atherosclerosis; 2012 Jan; 220(1):42-4. PubMed ID: 22093725
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease in south India.
    Pellicano R; Fagoonee S
    J Postgrad Med; 2011; 57(3):257-8. PubMed ID: 21941075
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic histology in obese patients undergoing bariatric surgery.
    Machado M; Marques-Vidal P; Cortez-Pinto H
    J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities and microvascular complications of type 2 diabetes in children and adolescents.
    Dean HJ; Sellers EA
    Pediatr Diabetes; 2007 Dec; 8 Suppl 9():35-41. PubMed ID: 17991131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.